Imatinib Mesylate for Chronic Myeloid Leukemia Survival

Imatinib Mesylate – The turning point for chronic Myeloid Leukemia Survival. This is a tyrosine kinase inhibitor indicated in the treatment of diagnosed chronic myeloid leukemia (CML). This is a condition, which involves an abnormality in the formation of myeloid stem cells, which have a role in the formation of platelets, red blood cells and […]